Boston Scientific Inc. (BSX): Today's Featured Health Care Winner

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

Boston Scientific ( BSX) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 0.8%. By the end of trading, Boston Scientific rose 21 cents (3%) to $7.31 on heavy volume. Throughout the day, 44 million shares of Boston Scientific exchanged hands as compared to its average daily volume of 16.3 million shares. The stock ranged in a price between $7.10-$7.38 after having opened the day at $7.14 as compared to the previous trading day's close of $7.10. Other companies within the Health Care sector that increased today were: ARCA biopharma ( ABIO), up 72.8%, Hemispherx Biopharma ( HEB), up 21.9%, ADVENTRX Pharmaceuticals ( ANX), up 21.3%, and BioClinica ( BIOC), up 19.4%.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $9.42 billion and is part of the health services industry. Shares are up 19.7% year to date as of the close of trading on Tuesday. Currently there are seven analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 15 rate it a hold.

TheStreet Ratings rates Boston Scientific as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity and weak operating cash flow.

On the negative front, Ventrus Biosciences ( VTUS), down 22.9%, Halozyme Therapeutics ( HALO), down 11.7%, Theratechnologies ( THER), down 10.3%, and Rockwell Medical ( RMTI), down 9.9%, were all laggards within the health care sector with Medivation ( MDVN) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE.

null

More from Markets

NYSE Suspends Trading for Some Shares of Amazon, Alphabet

NYSE Suspends Trading for Some Shares of Amazon, Alphabet

Stocks Slide Amid a Rise in Bond Yields, Strong Earnings

Stocks Slide Amid a Rise in Bond Yields, Strong Earnings

Video: Jim Cramer Reveals Why He's Cautious on Stocks

Video: Jim Cramer Reveals Why He's Cautious on Stocks

Jim Cramer on Earnings: All Stories Aren't Equal

Jim Cramer on Earnings: All Stories Aren't Equal

4 Stocks Making Important Moves Wednesday

4 Stocks Making Important Moves Wednesday